Skip to the page

Data / Form D filings / Novelix Pharmaceuticals Inc

Novelix Pharmaceuticals Inc: Form D filing

Novelix Pharmaceuticals Inc, a pharmaceuticals company in La Jolla, CA, filed a Form D with the SEC in 2009. The latest, on October 26, 2009, reports $253,103 sold of a $1.8 million offering to 10 investors.

Find out what Novelix Pharmaceuticals Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
8008 GIRARD AVE., SUITE 330, La Jolla, CA, 92037
Phone
(858) 454-3245
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506
SEC identifier (CIK)
1333263

The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 26, 2009New notice$1,750,000$253,103$1,496,89710Oct 8, 2009sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Timothy TricheDirector
Jeremy TeraokaExecutive Officer, Director
Burkhard JansenExecutive Officer, Director

Other pharmaceuticals companies in California that filed recently

Every Form D from the week of Oct 26, 2009 · All recent filings in California · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Novelix Pharmaceuticals Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.